Literature DB >> 27569441

Maximum benefit of chemotherapy for osteosarcoma achieved-what are the next steps?

Eugenie Kleinerman1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27569441     DOI： 10.1016/S1470-2045(16)30270-4

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  15 in total

1.  Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma.

Authors:  Pingting Zhou; Yanyan Li; Bo Li; Meichao Zhang; Ci Xu; Furao Liu; Lei Bian; Yuanhua Liu; Yuan Yao; Dong Li
Journal:  Cell Cycle       Date:  2018-06-25       Impact factor: 4.534

Review 2.  Provocative questions in osteosarcoma basic and translational biology: A report from the Children's Oncology Group.

Authors:  Ryan D Roberts; Michael M Lizardo; Damon R Reed; Pooja Hingorani; Jason Glover; Wendy Allen-Rhoades; Timothy Fan; Chand Khanna; E Alejandro Sweet-Cordero; Thomas Cash; Michael W Bishop; Meenakshi Hegde; Aparna R Sertil; Christian Koelsche; Lisa Mirabello; David Malkin; Poul H Sorensen; Paul S Meltzer; Katherine A Janeway; Richard Gorlick; Brian D Crompton
Journal:  Cancer       Date:  2019-07-29       Impact factor: 6.860

3.  Transition from Tumor Tissue to Bone Marrow in Patients with Appendicular Osteosarcoma after Neoadjuvant Chemotherapy.

Authors:  Zhi-Ping Deng; Bao-Yue Liu; Yang Sun; Tao Jin; Bin Li; Yi Ding; Xiao-Hui Niu
Journal:  Chin Med J (Engl)       Date:  2017-09-20       Impact factor: 2.628

4.  MicroRNA-542-3p suppresses tumor cell proliferation via targeting Smad2 inhuman osteosarcoma.

Authors:  Yinsheng Wu; Jiongming You; Feng Li; Feng Wang; Yong Wang
Journal:  Oncol Lett       Date:  2018-03-12       Impact factor: 2.967

5.  Vaccine efficacy against primary and metastatic cancer with in vitro-generated CD103+ conventional dendritic cells.

Authors:  Yifan Zhou; Natalie Slone; Taylor T Chrisikos; Oleksandr Kyrysyuk; Rachel L Babcock; Yusra B Medik; Haiyan S Li; Eugenie S Kleinerman; Stephanie S Watowich
Journal:  J Immunother Cancer       Date:  2020-04       Impact factor: 13.751

6.  Efficacy and safety of apatinib in treatment of osteosarcoma after failed standard multimodal therapy: An observational study.

Authors:  Zhichao Tian; Zhiyuan Gu; Xin Wang; Zhiyong Liu; Weitao Yao; Jiaqiang Wang; Peng Zhang; Qiqing Cai; Hong Ge
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

7.  A correlation analysis between tumor imaging changes and p-AKT and HSP70 expression in tumor cells after osteosarcoma chemotherapy.

Authors:  Feng Ji; Ran Lv; Ting Zhao
Journal:  Oncol Lett       Date:  2017-09-20       Impact factor: 2.967

8.  Metformin induces cell cycle arrest, apoptosis and autophagy through ROS/JNK signaling pathway in human osteosarcoma.

Authors:  Bo Li; Pingting Zhou; Kehan Xu; Tianrui Chen; Jian Jiao; Haifeng Wei; Xinghai Yang; Wei Xu; Wei Wan; Jianru Xiao
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 10.750

9.  hsa_circ0021347 as a Potential Target Regulated by B7-H3 in Modulating the Malignant Characteristics of Osteosarcoma.

Authors:  Ling Wang; Guo-Chuan Zhang; Fu-Biao Kang; Long Zhang; Ying-Ze Zhang
Journal:  Biomed Res Int       Date:  2019-12-17       Impact factor: 3.411

10.  The inhibition of microRNA-326 by SP1/HDAC1 contributes to proliferation and metastasis of osteosarcoma through promoting SMO expression.

Authors:  Jiang-Hu Huang; Yang Xu; Fei-Yue Lin
Journal:  J Cell Mol Med       Date:  2020-08-03       Impact factor: 5.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.